- Characteristics of study participants (N=66).
| Characteristics | n (%) |
|---|---|
| Gender | |
| Female | 31 (47.0) |
| Male | 35 (53.0) |
| Age group | |
| Pediatrics aged ≤14 years | 35 (53.0) |
| Adults aged ≥15 years | 31 (47.0) |
| Age at infection for patients aged ≤14 years (n=35) | 0.4 (0.25-2) |
| Age at infection for patients aged ≥15 years (n=31) | 51 (36-62) |
| Origin of infection | |
| Community-acquired | 13 (19.7) |
| Hospital-acquired | 53 (80.3) |
| Time between admission and positive culture (days) | 17 (6-37) |
| Admission location for hospital-acquired (n=53) | |
| General ward | 1 (1.9) |
| Critical care areas (ICU, OR, and ER) | 52 (98.1) |
| Previous hospitalization† | 48 (72.7) |
| Previous ICU admission† | 36 (75.0) |
| Underlying disease | |
| Metabolic disease | 4 (6.1) |
| Prematurity | 5 (7.6) |
| Solid tumors | 5 (7.6) |
| Seizure disorder | 5 (7.6) |
| Cerebrovascular disease | 7 (10.6) |
| Diabetes | 7 (10.6) |
| Hypertension | 11 (16.7) |
| Renal disease | 12 (18.2) |
| Hematology/oncology | 14 (21.2) |
| Immunodeficiency | 16 (24.2) |
| Liver disease | 16 (24.2) |
| Cardiovascular disease | 26 (39.4) |
| Respiratory disease | 27 (40.9) |
| Stem cell transplant | 7 (10.6) |
| Solid organ transplant | 13 (19.7) |
| Previous infection† | 38 (57.6) |
| Bacteria | 32 (84.2) |
| Fungus | 16 (42.1) |
| Previous antimicrobial use† | 55 (83.3) |
| Previous medications | |
| Immunosuppressant therapy | 20 (30.3) |
| Chemotherapy | 7 (10.6) |
| Clinical presentation | |
| Colonization | 5 (7.6) |
| Infection | 61 (92.4) |
| Symptoms for cases with infection presentation (n=61) | |
| Fever | 20 (32.8) |
| Tachycardia | 21 (34.4) |
| Hypotension | 14 (23) |
| Respiratory distress | 28 (45.9) |
| Lethargy | 11 (18) |
| Gastrointestinal symptoms | 4 (6.6) |
Values are presented as numbers and percentages (%) or median and interquartile range (IQR).
↵† Within one month before the episode (infection).
ICU: intensive care unit, OR: operation room, ER: emergency room